ZI

ZimVie IncNASDAQ ZIMV Stock Report

Last reporting period 30 Sep, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

0.439

Micro

Exchange

XNAS - Nasdaq

ZIMV Stock Analysis

ZI

Uncovered

ZimVie Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-14/100

Low score

Market cap $B

0.439

Dividend yield

Shares outstanding

26.222 B

ZimVie Inc. is a medical technology company. The Company develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

View Section: Eyestock Rating